These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22832289)

  • 1. Interleukin 1β blockade improves signs and symptoms of chronic calcium pyrophosphate crystal arthritis resistant to treatment.
    Diamantopoulos AP; Brodin C; Hetland H; Haugeberg G
    J Clin Rheumatol; 2012 Sep; 18(6):310-1. PubMed ID: 22832289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of resistant pseudogout with anakinra.
    McGonagle D; Tan AL; Madden J; Emery P; McDermott MF
    Arthritis Rheum; 2008 Feb; 58(2):631-3. PubMed ID: 18240249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra.
    Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Dasou P; Parissis J; Nikolaou M; Markantonis SL; Katsimbri P; Skarantavos G; Andreadou I; Anastasiou-Nana M
    Thromb Haemost; 2011 Nov; 106(5):959-67. PubMed ID: 21947196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature.
    Ottaviani S; Brunier L; Sibilia J; Maurier F; Ardizzone M; Wendling D; Gill G; Palazzo E; Meyer O; Dieudé P
    Joint Bone Spine; 2013 Mar; 80(2):178-82. PubMed ID: 23022422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis.
    Moltó A; Ea HK; Richette P; Bardin T; Lioté F
    Joint Bone Spine; 2012 Dec; 79(6):621-3. PubMed ID: 22658375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.
    Altomare A; Corrado A; Maruotti N; Cici D; Cantatore FP
    Mol Biol Rep; 2021 May; 48(5):4789-4796. PubMed ID: 34075537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
    Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
    Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure.
    Announ N; Palmer G; Guerne PA; Gabay C
    Joint Bone Spine; 2009 Jul; 76(4):424-6. PubMed ID: 19289295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances in therapies for calcium pyrophosphate crystal arthritis.
    Sivera F; Andrés M; Pascual E
    Curr Opin Rheumatol; 2016 Mar; 28(2):140-4. PubMed ID: 26780424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL1 blockade in crystal-induced arthritis: impact of disease duration and the inflammatory syndrome. Comments on the article by Couderc M. et al. "Efficacy of anakinra in articular chondrocalcinosis".
    Verhoeven F; Prati C; Godfrin-Valnet M; Guillot X; Wendling D
    Joint Bone Spine; 2013 Jan; 80(1):115-6. PubMed ID: 23103080
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium pyrophosphate dihydrate crystal induced arthropathy].
    Announ N; Guerne PA
    Rev Med Suisse; 2007 Mar; 3(103):740-2, 744, 746. PubMed ID: 17458152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudogout in 3 patients with presumed therapy-resistant rheumatoid arthritis].
    Vergunst CE; Tak PP
    Ned Tijdschr Geneeskd; 2005 Apr; 149(14):773-7. PubMed ID: 15835631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schnitzler syndrome: case report, the experience with glucocorticoid and anakinra (Kineret) therapies and monitoring of systemic cytokine response].
    Szturz P; Adam Z; Klabusay M; Fojtík Z; Kadanka Z; Stehlíková O; Chovancová J; Kalvodová L; Corbová D; Starý K; Neubauer J; Prásek J; Koukalová R; Rehák Z; Hájek R; Mayer J
    Vnitr Lek; 2011 Jan; 57(1):97-112. PubMed ID: 21351669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease.
    Lovell DJ; Bowyer SL; Solinger AM
    Arthritis Rheum; 2005 Apr; 52(4):1283-6. PubMed ID: 15818707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases.
    Thomas M; Forien M; Palazzo E; Dieudé P; Ottaviani S
    Clin Rheumatol; 2019 Feb; 38(2):425-430. PubMed ID: 30145636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Furst DE
    Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.